The precision of a report on precision


Por: Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Piñol, JAE and Borras, JM

Publicada: 1 mar 2026 Ahead of Print: 1 ene 2026
Resumen:


Filiaciones:
Mur, P:
 Biomed Res Inst Bellvitge, Dept Hlth, Catalonian Canc Strategy, IDIBELL, Barcelona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Pozuelo, A:
 Biomed Res Inst Bellvitge, Dept Hlth, Catalonian Canc Strategy, IDIBELL, Barcelona, Spain

Tabernero, J:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Vall dHebron Hosp Campus, Med Oncol Dept, Barcelona, Spain

 Vall dHebron Inst Oncol VHIO, Barcelona, Spain

Albanell, J:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Univ Pompeu Fabra, Hosp Del Mar Res Inst HMRIB, Canc Res Program, Med Oncol Dept,Hosp Del Mar, Barcelona, Spain

Bellosillo, B:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Univ Pompeu Fabra, Hosp Del Mar, Hosp Del Mar Res Inst HMRIB, Pathol Dept, Barcelona, Spain

Bosch, F:
 Vall dHebron Inst Oncol VHIO, Lab Expt Hematol, Barcelona, Spain

Briones, J:
 Hosp Santa Creu & Sant Pau, Hematol Dept, Barcelona, Spain

Brunet, J:
 Girona Biomed Res Inst IDIBGI, Catalan Inst Oncol ICO, Hereditary Canc Program, Girona, Spain

Colomer, D:
 Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Pathol Dept,Hematopathol Sect,Biomed Diagnost Ctr, Barcelona, Spain

Domènech, M:
 Xarxa Assistencial Univ Manresa, Med Oncol Dept, Fundacio Althaia, Manresa, Spain

Fontanet, JM:
 Med AreaCatalan Hlth Serv CatSalut, Div Rat Use Med, Barcelona, Spain

Matias-Guiu, X:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Bellvitge Univ Hosp, Dept Pathol, Barcelona, Spain

 Arnau Vilanova Univ Hosp, IDIBELL, Barcelona, Lleida, Spain

Salazar, R:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Univ Barcelona, Catalan Inst Oncol ICO, Med Oncol Dept, Clin Sci Dept, Bellvitge Campus, Barcelona, Spain

Vivanco-Hidalgo, RM:
 Agcy Hlth Qual & Assessment Catalonia AQuAS, Barcelona, Spain

Mollà, M:
 Univ Barcelona, Hosp Clin Barcelona, Radiat Oncol Dept, Barcelona, Spain

Moreno, L:
 Autonomous Univ Barcelona, Vall dHebron Univ Hosp, Vall dHebron Res Inst VHIR, Pediat Oncol & Hematol Dept, Barcelona, Spain

Prat, A:
 Univ Barcelona, Clin Barcelona Comprehens Canc Ctr, IDIBAPS, Barcelona, Spain

:
 Autonomous Univ Barcelona, Germans Trias Pujol I Hosp, Catalan Inst Oncol ICO, Josep Carreras Leukemia Res Inst IJC, Badalona, Spain

Clèries, R:
 Biomed Res Inst Bellvitge, Dept Hlth, Catalonian Canc Strategy, IDIBELL, Barcelona, Spain

 Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Barcelona, Spain

Guarga, A:
 Catalonian Hlth Serv CatSalut, Hlth Serv Procurement & Assessment, Barcelona, Spain

Piñol, JAE:
 Biomed Res Inst Bellvitge, Dept Hlth, Catalonian Canc Strategy, IDIBELL, Barcelona, Spain

Borras, JM:
 Biomed Res Inst Bellvitge, Dept Hlth, Catalonian Canc Strategy, IDIBELL, Barcelona, Spain

 Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Barcelona, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
Springer-Verlag Italia, GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND, Estados Unidos America
Tipo de documento: Letter
Volumen: 28 Número: 3
Páginas: 1076-1078
WOS Id: 001674204400001
ID de PubMed: 41610006

MÉTRICAS